The AHA joined by the Association of American Medical Colleges and America’s Essential Hospitals today will urge a federal court to prevent the Department of Health and Human Services from reducing Medicare payments under the 340B drug savings program by nearly 30% effective Jan. 1. In a brief to be filed today in reply to the agency’s motion to dismiss their lawsuit challenging the reduction, the hospital groups say the payment cut “far exceeds” HHS’s authority to adjust the reimbursement rate and warrants a preliminary injunction to prevent “imminent” and “actual” harm to their members. Thirty-two state and regional hospital associations also today will urge the court in a friend-of-the-court brief to grant the preliminary injunction, arguing that the estimated $1.6 billion cut “will have devastating consequences for safety-net providers and the millions of patients they serve.”

Headline
The 4th U.S. Circuit Court of AppealsMay 28 agreed to rehear challenges to 340B contract pharmacy laws from West Virginia and Maryland. In April, a three-judge…
Headline
The Wall Street Journal today published a letter to the editor from AHA General Counsel Chad Golder responding to a May 7 editorial criticizing the 340B Drug…
Headline
The White House May 18 announced an expansion of TrumpRx.gov, which now features more than 600 generic drugs. The direct-to-consumer platform serves as a hub…
Headline
The AHA today urged Eli Lilly to abandon its 340B Drug Pricing Program claims-data policy and work with the AHA to develop a functional third-party…
Headline
The Department of Health and Human Services yesterday announced an action plan on psychiatric prescribing, including efforts to initiate …
Headline
The AHA again is asking the Health Resources and Services Administration to take action after Eli Lilly warned hospitals that they could lose access to…